about
A large fraction of extragenic RNA pol II transcription sites overlap enhancersDifferential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionReciprocal insulation analysis of Hi-C data shows that TADs represent a functionally but not structurally privileged scale in the hierarchical folding of chromosomes.Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers.Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples.Fish the ChIPs: a pipeline for automated genomic annotation of ChIP-Seq data.Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity.Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts.Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells.Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractionsFishing for Function in the Human Gene Pool.HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles.The genomic landscapes of inflammation.Non-coding transcription at cis-regulatory elements: computational and experimental approaches.High constitutive activity of a broad panel of housekeeping and tissue-specific cis-regulatory elements depends on a subset of ETS proteinsTranscription of Mammalian cis-Regulatory Elements Is Restrained by Actively Enforced Early Termination.Limb-Enhancer Genie: An accessible resource of accurate enhancer predictions in the developing limb.HAND2 Target Gene Regulatory Networks Control Atrioventricular Canal and Cardiac Valve Development.Comparative evaluation of DNase-seq footprint identification strategies.Two functionally distinct subsets of mast cells discriminated By IL-2-independent CD25 activities.Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.Distal Limb Patterning Requires Modulation of cis-Regulatory Activities by HOX13.Ultraconserved Enhancers Are Required for Normal Development.Thrombopoietin signaling to chromatin elicits rapid and pervasive epigenome remodeling within poised chromatin architectures.Enhancer redundancy provides phenotypic robustness in mammalian development.A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic ActivitiesEnhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerControl of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiationTargeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationDissection of acute stimulus-inducible nucleosome remodeling in mammalian cellsNoncoding deletions reveal a gene that is critical for intestinal functionSingle-cell transcriptomics reveals multi-step adaptations to endocrine therapy
P50
Q21145794-C722020D-C9F9-4D3F-884F-5A261729AC0DQ27342622-09486A24-2B72-4263-AAA3-8CDC02FE1972Q31153179-B31DC153-E0EC-44E4-8D21-ACA0BC4A9B1DQ33723246-81A607DB-2940-4B8A-83BE-630DA4424008Q33755701-516F713A-AFB9-44A7-BFA5-E3D204704DFCQ34042235-7556548A-0616-4D75-822C-9CDAD698B419Q34388755-03334307-602D-4FD9-B4FE-40F138E246A8Q35882709-25696004-E233-42AC-925E-B585B89822FBQ35906160-CB20FF5E-5E12-4C69-9032-D1C720035E19Q36118451-CB325B6E-34EF-4594-AFD0-DB0DECA31CDEQ37018494-45B5CF93-A1D4-4FF3-A73F-BEFD1C8EFADBQ37729762-32DC5D9B-609C-46D3-815E-DBF0772A4DA1Q37829811-5121C748-177D-422A-9D5B-3CF9A4AC229DQ38094558-918748BD-567A-4163-ABB7-A763EB4C5379Q38919756-CD1B86C8-83F9-42F5-A223-E08179563C19Q40290186-02887BEB-80EF-4301-A488-2AEF6D0CC46DQ41577826-08AB6AE8-3B36-454A-BE25-EC156C4FB5FDQ42776614-10DFE6FC-2CEE-4323-B305-F00E17A3CDF4Q42792135-AE09D258-B6FD-430D-AD66-CD9D2807B26AQ42798859-E9DD6C52-1734-422C-8079-8081E13695C9Q43141233-ADB719D5-D3D9-4992-8AA4-FEDD4C6B53CEQ45976590-826F1C29-6EC2-4CC6-9D88-0CC004CAD16EQ47846669-6DA51685-8C19-4553-B93C-0FDB98433F44Q50074562-C51CCD1F-42C3-4E10-89A2-96DE519851A0Q50114986-BD1D9FB4-2339-48FC-937F-C4354E1C1E84Q54270777-7C746DC6-38EA-4ED3-A9BE-8A5D71A5A678Q58862440-730A9D39-8E9F-4580-997B-E391ADEEDD9EQ60683160-15DEAF51-856C-4D01-A7F7-753217B8E0A6Q62651867-D7903C40-DD27-4939-A415-CED1B6E132E2Q91878649-09D93D4C-0C1D-45FD-AA46-CE7554AEB7A7Q92351344-1A350506-7174-42D3-A73F-99A710DCEAC4Q92885990-D41ACF09-F982-4163-A771-0B05E7397286Q93063767-5779D994-8A9A-401F-86C4-55C73E0DC067
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Iros Barozzi
@en
Iros Barozzi
@nl
type
label
Iros Barozzi
@en
Iros Barozzi
@nl
prefLabel
Iros Barozzi
@en
Iros Barozzi
@nl
P31
P496
0000-0003-0690-3473